Cargando…

P1132: PET INTERIM RESULTS PREDICT PROGRESSION-FREE-SURVIVAL IN FOLLICULAR LYMPHOMA PATIENTS WITH ADVANCED STAGE

Detalles Bibliográficos
Autores principales:	Poza, M., Zamanillo, I., Íñiguez, R., Sarandeses, P., Rodriguez, A., Baumann, T., Barrio, S., Grande, C., Martin, A., Rufian, L., Martinez-Lopez, J., Jiménez-Ubieto, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430790/ http://dx.doi.org/10.1097/01.HS9.0000847396.16799.7f

Ejemplares similares

PB2091: INFLUENCE OF HISTOLOGICAL GRADE IN CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME OF FOLICULAR LYMPHOMA
por: Zamanillo, I., et al.
Publicado: (2022)

P1100: PET INTERIM RESULTS COULD PROMPTLY SELECT FOLLICULAR LYMPHOMA PATIENTS IN NEED OF MAINTENANCE THERAPY. POTENTIAL ADDITIONAL VALUE OF CFDNA.
por: Poza, Maria, et al.
Publicado: (2023)

P1284: LIQUID BIOPSY BY ULTRA-DEEP SEQUENCING PLUS PET-TC MONITORING IN REAL-LIFE FOLLICULAR LYMPHOMA PATIENTS
por: Jiménez-Ubieto, A., et al.
Publicado: (2022)

Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia
por: Poza, María, et al.
Publicado: (2021)

Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review
por: Adams, Hugo J. A., et al.
Publicado: (2015)

Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
por: Jiménez-Ubieto, Ana, et al.
Publicado: (2023)

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
por: Jiménez-Ubieto, Ana, et al.
Publicado: (2023)

Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Complementary Tool for the Diagnosis of B-Cell Lymphomas and the Surveillance of Measurable Residual Disease
por: Figaredo, Gloria, et al.
Publicado: (2023)

End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET
por: Chohan, Karan L., et al.
Publicado: (2022)

P1328: SUCCESFUL TREATMENT OF GRAFT FAILURE IN AUTOLOGOUS STEM CELL TRANSPLANTATION WITH CYCLOSPORINE
por: Cubillas, D., et al.
Publicado: (2022)

Prognostic values of baseline, interim and end-of therapy (18)F-FDG PET/CT in patients with follicular lymphoma
por: Zhou, Yeye, et al.
Publicado: (2019)

PET-Based Staging Is Cost-Effective in Early-Stage Follicular Lymphoma
por: Lo, Andrea C., et al.
Publicado: (2022)

Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma
por: Merryman, Reid W., et al.
Publicado: (2023)

Significance of initial, interim and end-of-therapy (18)F-FDG PET/CT for predicting transformation risk in follicular lymphoma
por: Xie, Mixue, et al.
Publicado: (2021)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
por: André, M., et al.
Publicado: (2011)

FDG-PET in Follicular Lymphoma Management
por: Bodet-Milin, C., et al.
Publicado: (2012)

1132. Professional Development Curriculum for Fellows in Infectious Diseases
por: Wells, jessica B, et al.
Publicado: (2020)

PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas
por: Barrington, Sally F., et al.
Publicado: (2016)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2022)

Interobserver variability in interim PET assessment in Hodgkin lymphoma—reasons and solutions
por: Georgi, Thomas W., et al.
Publicado: (2023)

Progression‐free survival at 2 years post‐autologous transplant: a surrogate end point for overall survival in follicular lymphoma
por: Jiménez‐Ubieto, Ana, et al.
Publicado: (2017)

Correction to Lancet Glob Health 2020; 8: e1132–41
Publicado: (2020)

Correction to Lancet Glob Health 2018; 6: e1132–38
Publicado: (2018)

Effect of soybean oligopeptide on the growth and metabolism of Lactobacillus acidophilus JCM 1132
por: Li, Wenhui, et al.
Publicado: (2020)

Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era
por: Song, Ga-Young, et al.
Publicado: (2020)

Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on (18)F-FDG PET-CT in Patients with Follicular Lymphoma
por: Liang, Jin-Hua, et al.
Publicado: (2019)

PB2270: PROGNOSTIC VALUE OF INTERIM POSITRON EMISSION TOMOGRAPHY IN HIGH-TUMOR-BURDEN FOLLICULAR LYMPHOMA
por: Argumánez, Marta Mora, et al.
Publicado: (2023)

Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma
por: Ollila, Thomas A, et al.
Publicado: (2021)

P1136: INTERIM IMAGING DOES NOT PREDICT CLINICAL EVOLUTION IN FOLLICULAR LYMPHOMA IN A REAL-LIFE CLINICAL SETTING
por: Ramos De Ascanio, V., et al.
Publicado: (2022)

Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma
por: So, Heejune, et al.
Publicado: (2023)

Radiotherapy in Follicular Lymphoma Staged by (18)F-FDG-PET/CT: A German Monocenter Study
por: Karsten, Imke E., et al.
Publicado: (2021)

SG-APSIC1132: BHQ isolation cart management at a Bangkok Hospital
por: Chomrak, Rome
Publicado: (2023)

Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial
por: Georgi, Thomas W., et al.
Publicado: (2020)

Radiotherapy for early and advanced stages Follicular Lymphoma
por: Mauro, Geovanne Pedro, et al.
Publicado: (2021)

1132. Pneumocystis Infection in Children: National Trends and Characteristics in the United States, 1997–2012
por: Inagaki, Kengo, et al.
Publicado: (2018)

FDG-PET Scan: a new Paradigm for Follicular Lymphoma Management
por: Gallamini, Andrea, et al.
Publicado: (2017)

New Treatment Options in Advanced Stage Follicular Lymphoma
por: Hübel, Kai, et al.
Publicado: (2018)

Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation Therapy
por: MacManus, Michael P., et al.
Publicado: (2020)

Prenatally diagnosed submicroscopic familial aberrations at 18p11.32 without phenotypic effect
por: Srebniak, Malgorzata I, et al.
Publicado: (2011)

Explorative analyses on the value of interim PET for prediction of response in pediatric and adolescent non-Hodgkin lymphoma patients
por: Furth, Christian, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_le65o69lltl9lv3r92qigqemol